We are very excited to be attending next week’s 12th Annual Meeting DIA Japan 2015, to be held at Tokyo Big Sight in Tokyo, November 15 – 17. It’s the first time that many of us based here in our U.S. headquarters will be joining our Japan team since opening our new Tokyo office over the summer. Under the theme “Medicine Development” this year’s event is set to focus on the innovative and constructive influence of patients on the enterprise of clinical R&D – a topic that’s always at the center of our work here at BBK.
Patient centricity continues to drive new conversations across the pharmaceutical, clinical R&D and life sciences industries; it’s an exciting time for those of us developing and delivering products and services that help support a more patient-centric approach to clinical research.
Japan is considered a leader in the area of postmarketing pharmaceutical safety evaluation, where generating data on the risks and benefits of medical products is among the most important steps in medicine development. Building on the discussions of previous DIA conferences, industry leaders will be talking about the patient’s role among the industry professionals, academics and government officials that help shape Japan’s medical development landscape.
We’re looking forward to meeting our partners and gaining new insights and valuable perspectives on the state of global clinical R&D in Japan. We’ll be reporting back on the key takeaways from this year’s DIA Japan meeting, so stay tuned for more.